Shandong Sanyuan Bio shows a total of 202.33 Million outstanding shares. Shandong Sanyuan Bio has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.58 % of Shandong Sanyuan outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Shandong Sanyuan in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Shandong Sanyuan, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Shandong
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Sanyuan Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Shandong Stock Ownership Analysis
About 62.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.14. In the past many companies with similar price-to-book ratios have beat the market. Shandong Sanyuan Bio last dividend was issued on the 10th of January 2025. The entity had 1.5:1 split on the 17th of June 2022. For more info on Shandong Sanyuan Biotechnology please contact the company at 86 54 3352 9851 or go to https://www.sanyuanbz.com.
Shandong Sanyuan Outstanding Bonds
Shandong Sanyuan issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Shandong Sanyuan Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Shandong bonds can be classified according to their maturity, which is the date when Shandong Sanyuan Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Shandong Sanyuan financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Sanyuan security.